booster shot

2022.01.14

10:20

J&J booster shot 85% effective against hospitalization by Omicron, SA study says

Asian Tech Press (Jan 14) -- A South African study shows that Johnson & Johnson's COVID-19 vaccine booster shot is up to 85% effective against hospitalization caused by the Omicron variant.

2022.01.06

03:49

U.S. CDC recommends Pfizer-BioNTech COVID-19 booster for ages 12-15

Asian Tech Press (Jan 6) -- The U.S. Centers for Disease Control and Prevention (CDC) recommended on Wednesday Pfizer-BioNTech COVID-19 booster doses for ages 12 to 15 years.

2021.12.31

09:25

U.S. FDA said to approve Pfizer-BioNTech COVID-19 booster for ages 12-15

Asian Tech Press (Dec 31) -- The U.S. Food and Drug Administration (FDA) plans to approve the use of Pfizer-BioNTech COVID-19 vaccine booster shot in children aged 12 to 15 next Monday, according to the New York Times, citing sources familiar with the matter.

2021.12.17

07:05

Japan PM calls with Pfizer CEO for early supply of COVID-19 vaccine booster

Asian Tech Press (Dec 17) -- Japanese Prime Minister Fumio Kishida reportedly spoke by phone Friday with Pfizer Inc. CEO Albert Bourla, asking for an early supply of COVID-19 vaccine booster shots.

2021.12.15

08:39

HKU study shows 2-dose course of Pfizer, Sinovac vax inadequate against Omicron

Asian Tech Press (Dec 15)-- Two doses of the Pfizer-BioNTech or Sinovac COVID-19 vaccine are inadequate against the Omicron variant, and a third dose is recommended as soon as possible, according to research released Tuesday by the University of Hong Kong (HKU).

2021.12.13

07:58

Pfizer booster shot effective against Omicron, Israeli study shows

Asian Tech Press (Dec 13) -- A new Israeli study shows that a booster dose of the COVID-19 vaccine Comirnaty, which was co-developed by Pfizer Inc. and German company BioNTech SE, is effective against the Omicron variant, the Wall Street Journal reported Sunday.

2021.12.10

10:02

U.S. FDA approves Pfizer-BioNTech COVID-19 booster for 16- and 17-year-olds

Asian Tech Press (Dec 10) -- The U.S. Food and Drug Administration (FDA) approved on Thursday a booster dose of the COVID-19 vaccine co-developed by Pfizer Inc. and German company BioNTech SE for 16- to 17-year-olds.

2021.11.19

15:38

U.S. FDA approves Pfizer, Moderna COVID-19 vaccine boosters for adults

Asian Tech Press (Nov 19) -- The U.S. Food and Drug Administration (FDA) has approved the emergency use for Pfizer and Moderna's COVID-19 vaccine boosters to all individuals 18 years of age and older on Friday, according to the Washington Post.

2021.11.17

11:25

Malaysia approves Sinovac, AstraZeneca's COVID-19 vaccines as booster shots

Asian Tech Press (Nov 17) -- Malaysia has conditionally approved Sinovac and AstraZeneca's COVID-19 vaccines as booster shots.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tesla's (TSLA.O) shares fell as much as 5% in pre-market trading after its fourth-quarter deliveries fell short of expectations.
                            2025-01-02

                                    Tesla (TSLA.O) produced 22,727 other models in the fourth quarter, compared with market forecasts of 22,790.
                            2025-01-02

                                    Yunding Technology: The company currently has no self-owned AI hardware products for sale
                            2025-01-02

                                    Tesla (TSLA.O) Model 3/Y production in the fourth quarter of 2024 was 436,718 units.
                            2025-01-02

                                    Tesla (TSLA.O) shares fell 2.7% in pre-market trading.
                            2025-01-02